LRRK2 in Parkinson's disease: building an understanding of disease etiology

被引：3
|
作者：
Braithwaite, Steven P. [1 ]
机构：
[1] Wyeth Ayerst Res, Princeton, NJ 08543 USA
来源：
FEBS JOURNAL | 2009年 / 276卷 / 22期
关键词：
D O I：
10.1111/j.1742-4658.2009.07340.x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：6427 / 6427
页数：1
相关论文
共 50 条
  • [21] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    [J]. NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [22] Lrrk2 pathogenic substitutions in Parkinson's disease
    Mata, IF
    Kachergus, JM
    Taylor, JP
    Lincoln, S
    Aasly, J
    Lynch, T
    Hulihan, MM
    Cobb, SA
    Wu, RM
    Lu, CS
    Lahoz, C
    Wszolek, ZK
    Farrer, MJ
    [J]. NEUROGENETICS, 2005, 6 (04) : 171 - 177
  • [23] Targeting LRRK2 mutations in Parkinson's disease
    Lesniak, Robert K.
    Nichols, Robert Jeremy
    Smith, Mark
    Montine, Thomas J.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1167 - 1170
  • [24] LRRK2 and the Endolysosomal System in Parkinson's Disease
    Erb, Madalynn L.
    Moore, Darren J.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291
  • [25] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    [J]. FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [26] Lrrk2 pathogenic substitutions in Parkinson's disease
    Ignacio F. Mata
    Jennifer M. Kachergus
    Julie P. Taylor
    Sarah Lincoln
    Jan Aasly
    Timothy Lynch
    Mary M. Hulihan
    Stephanie A. Cobb
    Ruey-Meei Wu
    Chin-Song Lu
    Carlos Lahoz
    Zbigniew K. Wszolek
    Matthew J. Farrer
    [J]. Neurogenetics, 2005, 6 : 171 - 177
  • [27] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [28] Pathological Functions of LRRK2 in Parkinson's Disease
    Jeong, Ga Ram
    Lee, Byoung Dae
    [J]. CELLS, 2020, 9 (12) : 1 - 19
  • [29] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [30] LRRK2 in Parkinson's disease: in vivo models and approaches for understanding pathogenic roles
    Yue, Zhenyu
    [J]. FEBS JOURNAL, 2009, 276 (22) : 6445 - 6454
12345